Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Blood Pressure Drug Recalled for Foreign Substance
07/14/2023
A prescription angiotensin receptor blocker indicated for use in patients with hypertension and nephropathy in patients with type 2 diabetes and a history of hypertension is being recalled.
A prescription angiotensin receptor blocker indicated for use in patients with hypertension and nephropathy in patients with type 2 diabetes and a history of hypertension is being recalled.
A prescription angiotensin...
07/14/2023
Pharmacy Learning Network

Advertisement

News
Measuring RSV Risk Awareness Among Adults With Diabetes
07/07/2023
Researchers explored knowledge, attitudes, and perceptions of respiratory syncytial virus (RSV) risk among US adults with diabetes to inform health care provider education efforts related to RSV awareness.
Researchers explored knowledge, attitudes, and perceptions of respiratory syncytial virus (RSV) risk among US adults with diabetes to inform health care provider education efforts related to RSV awareness.
Researchers explored knowledge,...
07/07/2023
Pharmacy Learning Network
News
Homeopathic Products Pulled
07/07/2023
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products have been issued a Class II recall after being distributed throughout the United States for deviations from Current Good Manufacturing Practices.
Multiple homeopathic products...
07/07/2023
Pharmacy Learning Network
News
Opioid Analgesic Recalled
07/07/2023
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been issued for prescription tramadol hydrochloride tablets due to a packaging defect.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network

Advertisement

News
Antifungal Injection Recalled
07/07/2023
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been issued for a prescription injectable, used to treat fungal infections, that was distributed throughout the United States.
A Class II recall has been...
07/07/2023
Pharmacy Learning Network
News
Label/Capsule Mix-Up Prompts Recall
06/30/2023
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to a product labeling mix-up for ziprasidone hydrochloride capsules and dronabinol capsules distributed throughout the United States.
A recall has been issued due to...
06/30/2023
Pharmacy Learning Network
News
Clinical Pharmacy Can Help Lower Adverse Drug Events in Patients With Cancer
06/29/2023
"Clinical pharmacy can reduce adverse drug events in cancer patients," explained study authors. "More robust and economic evaluations are still required to support its development in everyday practice."
"Clinical pharmacy can reduce adverse drug events in cancer patients," explained study authors. "More robust and economic evaluations are still required to support its development in everyday practice."
"Clinical pharmacy can reduce...
06/29/2023
Pharmacy Learning Network

Advertisement

News
Pharmacist-Based Naloxone Services Should Extend Beyond Community Pharmacy, Study Suggests
06/29/2023
A recent review aimed to identify the services provided by pharmacists regarding naloxone and their outcomes, and to examine the knowledge, attitudes, and barriers related to naloxone service provision in non-community pharmacy settings.
A recent review aimed to identify the services provided by pharmacists regarding naloxone and their outcomes, and to examine the knowledge, attitudes, and barriers related to naloxone service provision in non-community pharmacy settings.
A recent review aimed to...
06/29/2023
Pharmacy Learning Network
News
Once-Resistant Rural Court Officials Begin to Embrace Medications to Treat Addiction
06/29/2023
As evidence supporting medication treatment for opioid addiction mounts, judges, district attorneys, and law enforcement officials in rural America are increasingly open to it after years of insisting on abstinence only.
As evidence supporting medication treatment for opioid addiction mounts, judges, district attorneys, and law enforcement officials in rural America are increasingly open to it after years of insisting on abstinence only.
As evidence supporting...
06/29/2023
Pharmacy Learning Network
News
Understanding RSV Epidemiological Changes Amidst the COVID-19 Pandemic  
06/28/2023
Researchers provide a comprehensive overview of respiratory syncytial virus infection in the COVID-19 era, with insights into its epidemiology, prevention, and treatment strategies, as well as the key measures necessary for its containment in...
Researchers provide a comprehensive overview of respiratory syncytial virus infection in the COVID-19 era, with insights into its epidemiology, prevention, and treatment strategies, as well as the key measures necessary for its containment in...
Researchers provide a...
06/28/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use